Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Chinese Patent Office
Novartis
Cipla
Johnson and Johnson
Argus Health
QuintilesIMS
Fuji
AstraZeneca

Generated: February 20, 2018

DrugPatentWatch Database Preview

PHENDIMETRAZINE TARTRATE Drug Profile

« Back to Dashboard

When do Phendimetrazine Tartrate patents expire, and what generic alternatives are available?

Phendimetrazine Tartrate is a drug marketed by Graham Dm, Sandoz, Vitarine, Barr, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mikart, Nexgen Pharma Inc, Numark, Pvt Form, Solvay, Usl Pharma, and Watson Labs. and is included in sixty-five NDAs.

The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for PHENDIMETRAZINE TARTRATE
Drug patent expirations by year for PHENDIMETRAZINE TARTRATE
Pharmacology for PHENDIMETRAZINE TARTRATE

US Patents and Regulatory Information for PHENDIMETRAZINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kv Pharm PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085525-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Inwood Labs PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084740-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085402-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vitarine PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086005-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Nexgen Pharma Inc PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086020-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085497-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Solvay PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 083993-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vitarine PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086106-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Chartwell Rx PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085941-001 Jun 27, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Inwood Labs PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084741-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Moodys
Farmers Insurance
Johnson and Johnson
Teva
Cipla
Cantor Fitzgerald
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot